Wide Ranks

BNTC

Benitec Biopharma Inc.

9.73

Top Statistics
Market Cap 225 M Forward PE -1.03 Revenue Growth 0.00 %
Current Ratio 10.49 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -2.77 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 50 M Total Cash Per Share 4.82 Total Debt 284000
Total Debt To Equity 0.6010 Current Ratio 10.49 Book Value Per Share 4.68
All Measures
Short Ratio 135.00 % Message Board Id finmb_4492928 Shares Short Prior Month 53119
Return On Equity -0.9168 City Hayward Uuid b3cc27a2-16b5-3a55-8f58-57577c96b7a7
Previous Close 9.85 First Trade Date Epoch Utc 1 B Book Value 4.68
Beta 0.8790 Total Debt 284000 Volume 23229
Price To Book 2.08 Last Split Date 1 B Fifty Two Week Low 2.69
Total Cash Per Share 4.82 Shares Short Previous Month Date 1 B Target Median Price 30.95
Max Age 86400 Recommendation Mean 1.40 Sand P52 Week Change 0.3133
Last Dividend Value 0.7650 Target Mean Price 36.96 Net Income To Common -22370000
Short Percent Of Float 0.0072 Implied Shares Outstanding 23 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 35970 Average Volume10days 35970
Total Cash 50 M Next Fiscal Year End 1 B Held Percent Insiders 0.0439
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 9.85 Target Low Price 25.58 Gmt Off Set Milliseconds -18000000
Fifty Day Average 10.17 Open 9.98 Free Cashflow -11681250
State CA Dividend Yield 0.00 % Return On Assets -0.4960
Time Zone Short Name EST Trailing Eps -2.94 Day Low 9.70
Address1 3940 Trust Way Shares Outstanding 23 M Price Hint 2
Target High Price 54.16 Website https://benitec.com 52 Week Change 2.06
Average Volume 32917 Forward Eps -9.42 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 1037.70 % Last Split Factor 1:17
Regular Market Day High 9.98 Is_sp_500 False Profit Margins 0.00 %
Debt To Equity 0.6010 Fifty Two Week High 12.89 Day High 9.98
Shares Short 56887 Regular Market Open 9.98 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0029
Operating Cashflow -19403000 Currency USD Time Zone Full Name America/New_York
Market Cap 225 M Is_nasdaq_100 False Zip 94545
Quote Type EQUITY Industry Biotechnology Long Name Benitec Biopharma Inc.
Regular Market Day Low 9.70 Held Percent Institutions 0.8259 Current Price 9.73
Enterprise To Ebitda -2.77 Financial Currency USD Current Ratio 10.49
Industry Disp Biotechnology Number Of Analyst Opinions 5 Country United States
Float Shares 3 M Two Hundred Day Average 8.08 Enterprise Value 62 M
Forward PE -1.03 Regular Market Volume 23229 Last Dividend Date 1 B
Ebitda -22403000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions.

It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy.

Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.